The business world is constantly evolving, and as an investor, you need to evolve as well. If you can see tomorrow's opportunities today and adapt quickly, you'll have advantage when it comes to guaranteeing your long-term profits.
One company that has consistently stayed on the cutting edge of technological change in recent years is Stryker (SYK) . The Michigan-based company has been increasing its market share for several kinds of widely used medical devices. It has also shown a keen eye for making smart acquisitions in its field.
Shares of Stryker were roughly flat in Monday trading.
Stryker has operations in more than two dozen countries, although about 70% of its revenue still comes from sales in the U.S. It has been increasing its presence in China and India as those countries develop more sophisticated markets for advanced medical devices.
People are living longer than ever, and that has increased demand for therapies and devices to ensure they have a high quality of life. In addition, physicians, especially surgeons, are using equipment and techniques that no one had thought of 20 years ago. Stryker makes many of the leading devices, which it typically markets directly to doctors, hospitals and other health care facilities.
Stryker's product lines are in three major business segments: Reconstructive, Medical & Surgical, and Neurotechnology & Spine. Reconstructive products consist primarily of implants used in hip and knee joint replacements and trauma and extremities surgeries.